Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy

Oxaliplatin, a pivotal drug in the management of colorectal cancer, causes chemotherapy-induced peripheral neuropathy (CIPN) in a third of cancer survivors. Based on a previous cross-sectional study assessing oxaliplatin-related sensory CIPN in colorectal cancer survivors, a secondary analysis was d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerckhove, Nicolas, Selvy, Marie, Lambert, Céline, Gonneau, Coralie, Feydel, Gabrielle, Pétorin, Caroline, Vimal-Baguet, Agnès, Melnikov, Sergey, Kullab, Sharif, Hebbar, Mohamed, Bouché, Olivier, Slimano, Florian, Bourgeois, Vincent, Lebrun-Ly, Valérie, Thuillier, Frédéric, Mazard, Thibault, Tavan, David, Benmammar, Kheir Eddine, Monange, Brigitte, Ramdani, Mohamed, Péré-Vergé, Denis, Huet-Penz, Floriane, Bedjaoui, Ahmed, Genty, Florent, Leyronnas, Cécile, Busserolles, Jérôme, Trévis, Sophie, Pinon, Vincent, Pezet, Denis, Balayssac, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599933/
https://www.ncbi.nlm.nih.gov/pubmed/34803689
http://dx.doi.org/10.3389/fphar.2021.744085

Ejemplares similares

Ejemplares similares